Passage Bio, Inc. (PASG) Misses Q3 EPS by 8c

Passage Bio, Inc. (NASDAQ: PASG) reported Q3 EPS of ($0.31), $0.08 worse than the analyst estimate of ($0.23).

For earnings history and earnings-related data on Passage Bio, Inc. (PASG) click here.

You May Also Be Interested In

• Virtu Financial posts Q2 2026 preliminary results, seeks $400M loan
• Runway Growth Capital names new CFO in planned leadership shift
• Raymond James on Wells Fargo (WFC): 'We view the quarter positively'